Centre hospitalier de Soissons
Soissons, France
General hospital in Soissons
46 Av. du Général de Gaulle, 02200 Soissons
About Centre hospitalier de Soissons
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centre hospitalier de Soissons
During the past decade, Centre hospitalier de Soissons conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
2004-01-01
2009-04-01
Completed
134
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre hospitalier de Soissons" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials
sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored, "Groupe Hospitalier de la Region de Mulhouse et Sud Alsace" with 1 trials sponsored and "Hopital Foch"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre hospitalier de Soissons"
#1 collaborator was "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Institut National de la Santé et de la Recherche Médical (INSERM) 1086 (Pr Guy LAUNOY) Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centre hospitalier de Soissons
According to Clinical.Site data, the most researched conditions in "Centre hospitalier de Soissons" are
"Atrial Arrhythmia" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials), "Carcinoma" (1 trials) and "Clinical Research" (1 trials). Many other conditions were trialed in "Centre hospitalier de Soissons" in a lesser frequency.
Clinical Trials Intervention Types at Centre hospitalier de Soissons
Most popular intervention types in "Centre hospitalier de Soissons" are "Drug" (4 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (2 trials), "5-Fluoro-uracil" (1 trials), "Anastrozole" (1 trials), "Avelumab" (1 trials) and "Early consideration of vulnerability" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre hospitalier de Soissons
The vast majority of trials in "Centre hospitalier de Soissons" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Centre hospitalier de Soissons
Currently, there are NaN active trials in "Centre hospitalier de Soissons".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Centre hospitalier de Soissons,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centre hospitalier de Soissons, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".